UroGen Pharma
URGN
#5486
Rank
ยฃ1.02 B
Marketcap
ยฃ21.12
Share price
-1.12%
Change (1 day)
254.95%
Change (1 year)

Revenue for UroGen Pharma (URGN)

Revenue in 2025 (TTM): ยฃ81.84 Million

According to UroGen Pharma's latest financial reports the company's current revenue (TTM ) is ยฃ82.03 Million. an increase over the revenue in the year 2024 that were of ยฃ72.03 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for UroGen Pharma from 2017 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ81.52 M13.17%
2024 ยฃ72.03 M10.95%
2023 ยฃ64.92 M22.05%
2022 ยฃ53.19 M49.47%
2021 ยฃ35.59 M311.16%
2020 ยฃ8.65 M62960.72%
2019 ยฃ0.01 M-98.46%
2018 ยฃ0.88 M-85.28%
2017 ยฃ6.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA